Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Nat Methods. 2006 Oct;3(10):825–831. doi: 10.1038/NMETH931

Figure 5.

Figure 5

Dose-response curves determined with lysate microarrays. (a) MEK inhibitor U-0126; (b) PI3K inhibitor LY294002. For each antibody, normalized intensity values and fit curves were scaled relative to the maximum and minimum asymptotic values of the fit. Error bars represent the s.d. from three replicate wells.

HHS Vulnerability Disclosure